CRI Worldwide — Philadelphia, Pennsylvania

CRI Worldwide is a clinical research site located in Philadelphia, Pennsylvania, United States 19139.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

CRI Worldwide has participated in 20 clinical trials.

Therapeutic areas: Insomnia, Attention Deficit Hyperactivity Disorder, Major Depressive Disorder.

Sponsors: Sumitomo Pharma America, Inc., Euthymics BioScience, Inc., Cephalon.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CRI Worldwide?

CRI Worldwide has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CRI Worldwide conducted?

CRI Worldwide has 20 clinical trials on record. Their work covers Insomnia, Attention Deficit Hyperactivity Disorder, Major Depressive Disorder.

Is CRI Worldwide accredited by Crixeo Health?

Yes — CRI Worldwide holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about CRI Worldwide?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.